The targeted LNPs for extrahepatic delivery market is projected to reach $4.68B by 2030, driven by RNA therapeutics, tissue-specific delivery systems, ligand-directed nanoparticles, and modular nanocarrier platforms.
Read MoreThe systemic amyloidosis therapeutics market is projected to reach $8.88B by 2030, driven by targeted biologics, gene silencing therapies, monoclonal antibodies, and combination treatment protocols.
Read MoreThe super generics market is projected to reach $169.76B by 2030, driven by specialty generics, complex formulations, cost-effective therapies, and patient-friendly drug delivery innovations.
Read MoreThe single-use membrane chromatography systems market is projected to reach $1.96B by 2030, driven by gene and cell therapy growth, flexible purification adoption, and continuous bioprocessing innovations.
Read MoreThe recombinant vaccines market is projected to reach $28.07B by 2030 at 12.2% CAGR, driven by precision vaccines, emerging disease programs, adult boosters, and advanced recombinant platforms.
Read MoreThe recombinant proteins manufacturing services market is projected to reach $7.12B by 2030 at 14% CAGR, driven by protein therapeutics pipelines, pharma outsourcing, and GMP bioprocessing demand.
Read MoreThe recombinant human GCSF injection market is projected to reach $5.86B by 2030 at 8.6% CAGR, driven by cancer care demand, biosimilar adoption, and long-acting injectables.
Read MoreThe pyoderma gangrenosum treatment market is projected to reach $2.12B by 2030 at a 12.1% CAGR, driven by biologic therapies, combination drug regimens, advanced wound care, personalized treatments, and expanded clinical monitoring.
Read MoreThe polycythemia market is projected to reach $6.53B by 2030 at 7.0% CAGR, driven by JAK2-targeted therapies, personalized treatments, and advanced hematocrit monitoring.
Read MoreThe plant-derived analgesics market is projected to reach $5.06B by 2030 at 8.4% CAGR, driven by natural therapeutics adoption, cannabinoid growth, and advanced botanical pain therapies.
Read More